Type 2 diabetes is a common condition where the body cannot control blood sugar well. Over time, high blood sugar can damage many parts of the body, including the heart, kidneys, eyes, and nerves.
Because of this, doctors always look for better ways to help people keep their blood sugar at a healthy level.
A large international study has now taken a closer look at a medicine called semaglutide. This medicine is already used to treat type 2 diabetes, but researchers wanted to understand whether higher daily doses could work even better for people whose blood sugar is still too high.
The study was led by Dr. Vanita R. Aroda from a hospital in Boston. It brought together doctors and researchers from around the world. In total, the research took place in 14 different countries and involved 177 medical centers. This wide participation helped make the results more reliable and useful for many types of patients.
The researchers focused on people who were still struggling to control their blood sugar. These participants had HbA1c levels between 8.0 and 10.5 percent. HbA1c is a common blood test that shows average blood sugar levels over the past two to three months. A higher number means blood sugar has been too high for a long time.
All the participants were already taking one to three medicines to lower their blood sugar, but these treatments were not enough. Many of them also had higher body weight, which is common in type 2 diabetes and can make blood sugar harder to control.
The main goal of the study was simple. The researchers wanted to see whether taking semaglutide every day could further reduce HbA1c levels. They also wanted to find out which dose worked best and how safe the treatment was.
To do this, the participants were divided into three groups. Each group took a different daily dose of semaglutide. One group took 14 milligrams, another took 25 milligrams, and the third group took 50 milligrams. The treatment lasted for 68 weeks, which is a little more than one year.
During this time, doctors closely monitored the participants. They checked changes in blood sugar levels, body weight, and any side effects that appeared.
The results were clear. All three doses helped lower HbA1c levels, which means they improved blood sugar control. However, the higher doses of 25 milligrams and 50 milligrams worked better than the 14 milligram dose. People who took the stronger doses saw larger drops in their blood sugar levels.
In addition to better blood sugar control, participants taking the higher doses also lost more weight. This is important because weight loss can make it easier for the body to manage blood sugar and can improve overall health in people with type 2 diabetes.
However, there was a trade-off. People taking the higher doses were more likely to experience side effects. The most common problems were related to the stomach, such as nausea, vomiting, or diarrhea. These side effects were usually mild and did not last forever, but they happened more often in the groups taking the stronger doses.
This means that while higher doses of semaglutide can be more effective, they may not be the best choice for everyone. Doctors will need to balance the benefits of better blood sugar control and weight loss with the risk of side effects when deciding on the right dose for each patient.
Overall, this study provides helpful new information. For people whose blood sugar remains high despite taking other medications, higher daily doses of semaglutide may offer a stronger option. At the same time, careful monitoring is important to make sure the treatment is safe and comfortable.
The findings from this large international study were published in the medical journal The Lancet. The results may help guide future treatment decisions and give patients and doctors more choices when managing type 2 diabetes.
If you care about diabetes, please read studies that eating more eggs is linked to a higher risk of type 2 diabetes, and how to eat to reduce heart disease death risk if you have diabetes.
For more health information, please see recent studies about high-protein diets linked to a higher risk of type 2 diabetes, and results showing Mediterranean diet could help reduce the diabetes risk by one-third.
Copyright © 2026 Knowridge Science Report. All rights reserved.
